138 results
424B3
NVIVQ
InVivo Therapeutics Holdings Corp
21 Nov 22
Prospectus supplement
4:48pm
We are a research and clinical-stage biomaterials and biotechnology company with a focus on treatment of spinal cord injuries, or SCIs. Our approach
8-K
EX-99.1
u5tk9rhk6w6n jyjl10e
11 Oct 22
InVivo Therapeutics Announces $9 Million Registered Direct and Private Placement
4:23pm
424B5
ywrltpzr
11 Oct 22
Prospectus supplement for primary offering
11:07am
8-K
EX-99.1
wrl4vu6a rtob48juxb
2 Jun 22
InVivo Therapeutics Announces Completion of Enrollment
8:35am
DEFA14A
pdsbg
6 Jul 21
Additional proxy soliciting materials
8:10am
424B4
5r6lydanp xxkuzw1s
26 Oct 20
Prospectus supplement with pricing info
12:00am